AMENDMENT TO STOCK PURCHASE AND SALE AGREEMENTStock Purchase and Sale Agreement • May 14th, 2019 • Progenics Pharmaceuticals Inc • Pharmaceutical preparations
Contract Type FiledMay 14th, 2019 Company IndustryThis Amendment to Stock Purchase and Sale Agreement (this “Amendment”) is made as of the 9th day of May, 2019, by and among Highland Capital Management, L.P., solely in its capacity as stockholders’ representative (the “Stockholders Representative”), Molecular Insight Pharmaceuticals, Inc. (“MIP”), and Progenics Pharmaceuticals, Inc. (“Progenics”).